荧光共聚焦显微镜在机器人辅助根治性前列腺切除术中行术中切缘评估的首次经验
最终分析101例,从标本取出到术中报告的中位时间为13分钟,对任何阳性切缘的敏感度88.2%、特异度91.7%、总体准确率91.1%;对临床显著阳性切缘(≥3 mm)的敏感度93.8%、特异度91.8%、总体准确率92.1%。结论为该方法可行且诊断准确性良好, turnaround时间与常规手术流程兼容。
要点
- 荧光共聚焦显微镜术中评估切缘可行,中位报告时间13分钟。
- 对任何阳性切缘敏感度88.2%、特异度91.7%、准确率91.1%。
- 对≥3 mm临床显著阳性切缘诊断性能更优,准确率92.1%。
核心结论
- 术中荧光共聚焦显微镜评估前列腺切缘可行,与最终病理相比诊断准确性良好,周转时间与常规手术流程兼容。
- 当采用临床相关阳性切缘长度阈值(≥3 mm)时,诊断性能有所提高。
- 需更大规模多中心研究和随机试验确定荧光共聚焦显微镜引导的术中决策能否改善肿瘤学和功能结局。
研究设计与样本
- 术中采用荧光共聚焦显微镜(Histolog® Scanner;SamanTree Medical SA,Lausanne,Switzerland)对前列腺标本行离体扫描。
- 数字图像由经验丰富的泌尿病理医生在盲法下实时远程判读,最终组织病理学评估作为参考标准。
- 排除初始学习曲线病例和不可判读扫描后,最终分析101例患者。
主要发现
- 从前列腺取出到术中报告的中位(四分位距)总时间为13(6-16)分钟。
- 最终病理显示17例患者(17%)存在阳性切缘。
- 检测任何阳性切缘:荧光共聚焦显微镜敏感度88.2%、特异度91.7%、阳性预测值68.2%、阴性预测值97.5%、总体诊断准确率91.1%。
- 检测临床显著阳性切缘(≥3 mm):敏感度93.8%、特异度91.8%、阳性预测值68.2%、阴性预测值98.7%、总体准确率92.1%。
临床怎么用
- 可在机器人辅助根治性前列腺切除术中采用荧光共聚焦显微镜对前列腺标本行离体切缘评估,中位13分钟获得术中报告。
- 判读时需关注临床显著阳性切缘(≥3 mm)阈值,该阈值下诊断性能更优。
- 该方法可作为术中切缘评估工具,但其对肿瘤学和功能结局的影响尚待更大规模研究确定。
局限性
- 研究为单中心前瞻性观察研究,最终分析仅101例。
- 排除了初始学习曲线病例和不可判读扫描。
- 荧光共聚焦显微镜引导的术中决策对肿瘤学和功能结局的影响尚未确定,需更大规模多中心研究和随机试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the feasibility of adopting fluorescence confocal microscopy (FCM) for intraoperative assessment of positive surgical margins (PSMs) during robot-assisted radical prostatectomy (RARP) in a real-world clinical setting. PATIENTS AND METHODS: We conducted a prospective observational study including consecutive patients undergoing RARP between October 2023 and November 2024 in whom intraoperative margin assessment was performed using FCM (Histolog® Scanner; SamanTree Medical SA, Lausanne, Switzerland). After exclusion of initial learning-curve cases and non-interpretable scans, a per-patient analysis was performed. Prostate specimens were scanned ex vivo intraoperatively, and digital images were reviewed remotely and in real time by an experienced uropathologist blinded to final pathology. Final histopathological evaluation served as the reference standard. Diagnostic performance metrics included sensitivity, specificity, positive predictive value (PPV), negative PV (NPV), and overall accuracy, assessed both for any PSM and for clinically significant PSMs (≥3 mm). RESULTS: A total of 101 patients were included in the final analysis. The median (interquartile range) overall time from prostate extraction to intraoperative report was 13 (6-16) min. At final pathology, 17 patients (17%) had PSMs. For detection of any PSM, FCM demonstrated a sensitivity of 88.2%, specificity of 91.7%, PPV of 68.2%, and NPV of 97.5%, with an overall diagnostic accuracy of 91.1%. When restricting the analysis to clinically significant PSMs (≥3 mm), diagnostic performance improved, with sensitivity, specificity, PPV, and NPV of 93.8%, 91.8%, 68.2%, and 98.7%, respectively, and an overall accuracy of 92.1%. CONCLUSIONS: Intraoperative surgical margin assessment using FCM is feasible and demonstrates good diagnostic accuracy compared with final histopathology, with rapid turnaround times compatible with routine surgical workflows. Diagnostic performance improves when clinically relevant PSM length thresholds are applied. Larger multicentre studies and randomised trials are warranted to determine whether FCM-guided intraoperative decision-making can improve oncological and functional outcomes after RARP.
引用
- de Angelis M, Beatrici E, Penaranda NR, et al. Intraoperative margin assessment using fluorescence confocal microscopy during robot-assisted radical prostatectomy: a first experience. BJU Int. 2026. PMID: 41877464. doi:10.1111/bju.70262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。